European molecular testing leader Qiagen (QGEN.US) accepts EQT acquisition offer: 46.50 per share, a 40.3% premium to July share price.

Zhitong Finance APP has learned that Qiagen (QGEN.US) said on Thursday that it has agreed to accept a all-cash public takeover offer from private equity firm EQT Group, in a deal that values the European molecular testing company at approximately 10.8 billion euros.